Tenaya Therapeutics Inc. (TNYA) NASDAQ
$5.29 0.13 (2.52%)
Market Cap: $405.14M
As of 03/28/24 09:30 AM EDT. Market open.
Tenaya Therapeutics Inc. (TNYA)
NASDAQ
$5.29
0.13 (2.52%)
Market Cap: $405.14M
As of 03/28/24 09:30 AM EDT. Market open.
tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies ... read more
tenaya therapeutics is a privately-held biopharmaceutical company backed by the column group. the company was founded in 2016 by world-leading scientists from the gladstone institute’s cardiovascular division and the university of texas southwestern medical center. tenaya is dedicated to addressing heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration. tenaya has a lead gene therapy program focused on in vivo reprogramming of cardiac fibroblasts to cardiomyocytes to regenerate heart tissue, and additional programs focused on cardiomyopathies. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hoey Timothy | Chief Scientific Officer | Mar 05, 2024 | Sale | $7.00 | 3,300 | 23,101 | 245,346 | Mar 06, 2024, 06:45 PM |
Hoey Timothy | Chief Scientific Officer | Feb 20, 2024 | Sale | $5.34 | 6,569 | 35,046 | 236,346 | Feb 21, 2024, 06:05 PM |
Hoey Timothy | Chief Scientific Officer | Feb 16, 2024 | Sale | $5.86 | 4,681 | 27,431 | 242,715 | Feb 16, 2024, 08:37 PM |
Tingley Whittemore | Chief Medical Officer | Feb 16, 2024 | Sale | $5.86 | 6,500 | 38,090 | 73,534 | Feb 16, 2024, 08:35 PM |
PATTERSON LEONE D | Chief Fin. and Bus. Officer | Feb 16, 2024 | Sale | $5.86 | 5,201 | 30,478 | 60,755 | Feb 16, 2024, 08:32 PM |
Ali Faraz | Chief Executive Officer | Feb 16, 2024 | Sale | $5.86 | 6,358 | 37,258 | 113,079 | Feb 16, 2024, 08:30 PM |
COLUMN GROUP III GP, LP | 10% Owner | Feb 12, 2024 | Buy | $4.50 | 2,222,222 | 9,999,999 | 13,599,275 | Feb 14, 2024, 04:15 PM |
GOEDDEL DAVID V | Director | Feb 12, 2024 | Buy | $4.50 | 2,222,222 | 9,999,999 | 13,599,275 | Feb 14, 2024, 04:12 PM |
Hoey Timothy | Chief Scientific Officer | Aug 29, 2023 | Sale | $4.26 | 7,243 | 30,855 | 247,396 | Aug 29, 2023, 06:59 PM |
Hoey Timothy | Chief Scientific Officer | Aug 16, 2023 | Sale | $3.81 | 4,007 | 15,267 | 254,639 | Aug 18, 2023, 06:34 PM |
Tingley Whittemore | Chief Medical Officer | Aug 16, 2023 | Sale | $3.81 | 5,563 | 21,195 | 76,437 | Aug 18, 2023, 06:33 PM |
PATTERSON LEONE D | Chief Fin. and Bus. Officer | Aug 16, 2023 | Sale | $3.81 | 4,452 | 16,962 | 64,542 | Aug 18, 2023, 06:31 PM |
Ali Faraz | Chief Executive Officer | Aug 16, 2023 | Sale | $3.81 | 5,563 | 21,195 | 119,437 | Aug 18, 2023, 06:31 PM |
COLUMN GROUP III GP, LP | 10% Owner | Mar 10, 2023 | Buy | $2.60 | 6,779 | 17,596 | 11,377,053 | Mar 14, 2023, 04:12 PM |
GOEDDEL DAVID V | Director | Mar 10, 2023 | Buy | $2.60 | 6,779 | 17,596 | 11,377,053 | Mar 14, 2023, 04:09 PM |
COLUMN GROUP III GP, LP | 10% Owner | Feb 08, 2023 | Buy | $2.60 | 1,500,000 | 3,900,000 | 11,370,274 | Feb 10, 2023, 04:32 PM |
GOEDDEL DAVID V | Director | Feb 08, 2023 | Buy | $2.60 | 1,500,000 | 3,900,000 | 11,370,274 | Feb 10, 2023, 04:22 PM |
COLUMN GROUP III GP, LP | 10% Owner | Jan 19, 2023 | Buy | $2.50 | 69,739 | 174,201 | 9,870,274 | Jan 23, 2023, 04:25 PM |
GOEDDEL DAVID V | Director | Jan 19, 2023 | Buy | $2.50 | 69,739 | 174,201 | 9,870,274 | Jan 23, 2023, 04:21 PM |
COLUMN GROUP III GP, LP | 10% Owner | Jan 17, 2023 | Buy | $2.49 | 49,463 | 123,395 | 9,664,847 | Jan 19, 2023, 04:18 PM |
COLUMN GROUP III GP, LP | 10% Owner | Jan 18, 2023 | Buy | $2.52 | 135,688 | 341,432 | 9,800,535 | Jan 19, 2023, 04:18 PM |
GOEDDEL DAVID V | Director | Jan 18, 2023 | Buy | $2.52 | 135,688 | 341,432 | 9,800,535 | Jan 19, 2023, 04:13 PM |
GOEDDEL DAVID V | Director | Jan 17, 2023 | Buy | $2.49 | 49,463 | 123,395 | 9,664,847 | Jan 19, 2023, 04:13 PM |
Srivastava Deepak | Director | Nov 21, 2022 | Buy | $2.60 | 230,769 | 599,999 | 372,435 | Dec 09, 2022, 07:59 PM |
Casdin Eli | Director | Nov 17, 2022 | Buy | $2.60 | 2,492,042 | 6,479,309 | 6,078,860 | Nov 25, 2022, 07:05 PM |
COLUMN GROUP III GP, LP | 10% Owner | Nov 21, 2022 | Buy | $2.60 | 9,615,384 | 24,999,997 | 9,615,384 | Nov 23, 2022, 04:12 PM |
GOEDDEL DAVID V | Director | Nov 21, 2022 | Buy | $2.60 | 9,615,384 | 24,999,997 | 9,615,384 | Nov 23, 2022, 04:11 PM |
Hoey Timothy | Chief Scientific Officer | Apr 26, 2022 | Sale | $10.13 | 1,353 | 13,706 | 198,646 | Apr 28, 2022, 07:57 PM |
Casdin Partners Master Fund, L.P. | 10% Owner | Aug 03, 2021 | Buy | $15.00 | 850,000 | 12,750,000 | 3,224,849 | Aug 04, 2021, 06:33 PM |
Casdin Eli | Director | Aug 03, 2021 | Buy | $15.00 | 850,000 | 12,750,000 | 3,224,849 | Aug 04, 2021, 06:32 PM |
Owner | Relationship | Date | Value($) |
Hoey Timothy | Chief Scientific Officer | 03/05/2024 | 23,101 |
Hoey Timothy | Chief Scientific Officer | 02/20/2024 | 35,046 |
Hoey Timothy | Chief Scientific Officer | 02/16/2024 | 27,431 |
Tingley Whittemore | Chief Medical Officer | 02/16/2024 | 38,090 |
PATTERSON LEONE D | Chief Fin. and Bus. Officer | 02/16/2024 | 30,478 |
Ali Faraz | Chief Executive Officer | 02/16/2024 | 37,258 |
COLUMN GROUP III GP, LP | 10% Owner | 02/12/2024 | 9,999,999 |
GOEDDEL DAVID V | Director | 02/12/2024 | 9,999,999 |
Hoey Timothy | Chief Scientific Officer | 08/29/2023 | 30,855 |
Hoey Timothy | Chief Scientific Officer | 08/16/2023 | 15,267 |
Tingley Whittemore | Chief Medical Officer | 08/16/2023 | 21,195 |
PATTERSON LEONE D | Chief Fin. and Bus. Officer | 08/16/2023 | 16,962 |
Ali Faraz | Chief Executive Officer | 08/16/2023 | 21,195 |
COLUMN GROUP III GP, LP | 10% Owner | 03/10/2023 | 17,596 |
GOEDDEL DAVID V | Director | 03/10/2023 | 17,596 |
COLUMN GROUP III GP, LP | 10% Owner | 02/08/2023 | 3,900,000 |
GOEDDEL DAVID V | Director | 02/08/2023 | 3,900,000 |
COLUMN GROUP III GP, LP | 10% Owner | 01/19/2023 | 174,201 |
GOEDDEL DAVID V | Director | 01/19/2023 | 174,201 |
COLUMN GROUP III GP, LP | 10% Owner | 01/17/2023 | 123,395 |
COLUMN GROUP III GP, LP | 10% Owner | 01/18/2023 | 341,432 |
GOEDDEL DAVID V | Director | 01/18/2023 | 341,432 |
GOEDDEL DAVID V | Director | 01/17/2023 | 123,395 |
Srivastava Deepak | Director | 11/21/2022 | 599,999 |
Casdin Eli | Director | 11/17/2022 | 6,479,309 |
COLUMN GROUP III GP, LP | 10% Owner | 11/21/2022 | 24,999,997 |
GOEDDEL DAVID V | Director | 11/21/2022 | 24,999,997 |
Hoey Timothy | Chief Scientific Officer | 04/26/2022 | 13,706 |
Casdin Partners Master Fund, L.P. | 10% Owner | 08/03/2021 | 12,750,000 |
Casdin Eli | Director | 08/03/2021 | 12,750,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 5,507,347 | 0.28% | -18.03% | Other |
BLACKROCK INC. | 3,786,824 | 0.00031% | -19.14% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 928,763 | 0.00031% | 6.36% | Other |
RENAISSANCE TECHNOLOGIES LLC | 482,325 | 0.00242% | 11.24% | Other |
D. E. SHAW & CO., INC. | 95,567 | 0.00027% | -23.33% | Other |
BALYASNY ASSET MANAGEMENT L.P. | 26,228 | 0.00014% | Exited | Event Driven |
AQR CAPITAL MANAGEMENT LLC | 23,394 | 0.00014% | 58.66% | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View